Akero Therapeutics Inc buy Bank of America Co.
Start price
27.05.25
/
50%
€42.17
Target price
27.05.26
€56.17
Performance (%)
11.38%
Price
08.12.25
€46.97
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ currently has a performance of 11.38%. This prediction currently runs until 27.05.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akero Therapeutics Inc | - | - |
| iShares Core DAX® | -1,42 % | 8,92 % |
| iShares Nasdaq 100 | 3,27 % | 16,28 % |
| iShares Nikkei 225® | 1,75 % | 16,24 % |
| iShares S&P 500 | 1,45 % | 10,91 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target raised by analysts at Bank of America Co. from $63.00 to $64.00. They now have a "buy" rating on the stock.
Ratings data for AKRO provided by MarketBeat